Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

July 2, 2020
Open Access

Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment

Risk Management and Healthcare Policy
Monica ZolezziSowndramalingam Sankaralingam
July 1, 2020

Performance of CVD risk equations for older patients assessed in general practice: a cohort study

The New Zealand Medical Journal
Sue WellsRod Jackson
July 1, 2020

Rheumatoid Arthritis: Pathogenesis, Prediction and Prevention - An Emerging Paradigm Shift

Arthritis & Rheumatology
Kevin D Deane, V Michael Holers
July 1, 2020

Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases

Terapevticheskiĭ arkhiv
I A OlkhovskiyT L Martsinkevich
July 1, 2020
Open Access

IGFBP-4 enhances VEGF-induced angiogenesis in a mouse model of myocardial infarction

Journal of Cellular and Molecular Medicine
Da WoDan-Ni Ren
July 1, 2020
Open Access

Galactin-3: diagnostic and prognostic value in patients with chronic heart failure

Terapevticheskiĭ arkhiv
A M AliyevaE V Reznik
July 1, 2020

Effects of transcutaneous cardiac pacing on ventricular repolarization and comparison with transvenous pacing

Pacing and Clinical Electrophysiology : PACE
Fani ZagkliJohn Chiladakis
July 2, 2020
Comment / Editorial
Open Access

Dairy Fat and Cardiovascular Health

Foods
Esther Sendra
July 1, 2020
Review
Open Access

Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans

Arhiv za higijenu rada i toksikologiju
Ankica SekovanićMartina Piasek

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/biomarkers-for-cardiovascular-risk/6206ce3c-e7b0-48bb-8104-1ef3a959b60c